|
1
|
Ishitsuka K and Tamura K: Human T-cell
leukaemia virus type I and adult T-cell leukaemia-lymphoma. Lancet
Oncol. 15:e517–e526. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tsukasaki K, Utsunomiya A, Fukuda H,
Shibata T, Fukushima T, Takatsuka Y, Ikeda S, Masuda M, Nagoshi H,
Ueda R, et al: VCAP-AMP-VECP compared with biweekly CHOP for adult
T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study
JCOG9801. J Clin Oncol. 25:5458–64. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hishizawa M, Kanda J, Utsunomiya A,
Taniguchi S, Eto T, Moriuchi Y, Tanosaki R, Kawano F, Miyazaki Y,
Masuda M, et al: Transplantation of allogeneic hematopoietic stem
cells for adult T-cell leukemia: A nationwide retrospective study.
Blood. 116:1369–1376. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shigematsu A, Kobayashi N, Yasui H, Shindo
M, Kakinoki Y, Koda K, Iyama S, Kuroda H, Tsutsumi Y, Imamura M and
Teshima T: High level of serum soluble interleukin-2 receptor at
transplantation predicts poor outcome of allogeneic stem cell
transplantation for adult T cell leukemia. Biol Blood Marrow
Transpl. 20:801–805. 2014. View Article : Google Scholar
|
|
5
|
Ishida T, Joh T, Uike N, Yamamoto K,
Utsunomiya A, Yoshida S, Saburi Y, Miyamoto T, Takemoto S,
Suzushima H, Tsukasaki K, et al: Defucosylated anti-CCR4 monoclonal
antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: A
multicenter phase II study. J Clin Oncol. 30:837–842. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bazarbachi A, Plumelle Y, Carlos Ramos J,
Tortevoye P, Otrock Z, Taylor G, Gessain A, Harrington W, Panelatti
G and Hermine O: Meta-analysis on the use of zidovudine and
interferon-alfa in adult T-cell leukemia/lymphoma showing improved
survival in the leukemic subtypes. J Clin Oncol. 28:4177–4183.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bazarbachi A, Nasr R, El-Sabban ME, Mahé
A, Mahieux R, Gessain A, Darwiche N, Dbaibo G, Kersual J, Zermati
Y, et al: Evidence against a direct cytotoxic effect of alpha
interferon and zidovudine in HTLV-I associated adult T cell
leukemia/lymphoma. Leukemia. 14:716–721. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kchour G, Tarhini M, Kooshyar MM, El Hajj
H, Wattel E, Mahmoudi M, Hatoum H, Rahimi H, Maleki M, Rafatpanah
H, et al: Phase 2 study of the efficacy and safety of the
combination of arsenic trioxide, interferon alpha, and zidovudine
in newly diagnosed chronic adult T-cell leukemia/lymphoma (ATL).
Blood. 113:6528–6532. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dassouki Z, Sahin U, El Hajj H, Jollivet
F, Kfoury Y, Lallemand-Breitenbach V, Hermine O, de Thé H and
Bazarbachi A: ATL response to arsenic/interferon therapy is
triggered by SUMO/PML/RNF4-dependent Tax degradation. Blood.
125:474–482. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Takeda S, Maeda M, Morikawa S, Taniguchi
Y, Yasunaga J, Nosaka K, Tanaka Y and Matsuoka M: Genetic and
epigenetic inactivation of tax gene in adult T-cell leukemia cells.
Int J Cancer. 109:559–567. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shimoyama M: Diagnostic criteria and
classification of clinical subtypes of adult T-cell
leukaemia-lymphoma. A report from the Lymphoma Study Group
(1984–87). Br J Haematol. 79:428–437. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Arima N, Molitor JA, Smith MR, Kim JH,
Daitoku Y and Greene WC: Human T-cell leukemia virus type I Tax
induces expression of the Rel-related family of kappa B
enhancer-binding proteins: Evidence for a pretranslational
component of regulation. J Virol. 65:6892–6899. 1991.PubMed/NCBI
|
|
13
|
Takemoto S, Matsuoka M, Yamaguchi K and
Takatsuki K: A novel diagnostic method of adult T-cell leukemia:
Monoclonal integration of human T-cell lymphotropic virus type I
provirus DNA detected by inverse polymerase chain reaction. Blood.
84:3080–3085. 1994.PubMed/NCBI
|
|
14
|
Yoshida M, Miyoshi I and Hinuma Y: A
retrovirus from human leukemia cell lines: Its isolation,
characterization, and implication in human adult T-cell leukemia
(ATL). Princess Takamatsu Symp. 12:285–294. 1982.PubMed/NCBI
|
|
15
|
Lee B, Tanaka Y and Tozawa H: Monoclonal
antibody defining tax protein of human T-cell leukemia virus
type-I. Tohoku J Exp Med. 157:1–11. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Szumiel I and Nias AH: Isobologram
analysis of the combined effects of anti-tumour platinum complexes
and ionizing radiation on mammalian cells. Br J Cancer. 42:292–296.
1980. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kanda Y: Investigation of the freely
available easy-to-use software ‘EZR’ for medical statistics. Bone
Marrow Transpl. 48:452–458. 2013. View Article : Google Scholar
|
|
18
|
Susin SA, Lorenzo HK, Zamzami N, Marzo I,
Snow BE, Brothers GM, Mangion J, Jacotot E, Costantini P, Loeffler
M, et al: Molecular characterization of mitochondrial
apoptosis-inducing factor. Nature. 397:441–446. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
El-Sabban ME, Nasr R, Dbaibo G, Hermine O,
Abboushi N, Quignon F, Ameisen JC, Bex F, de Thé H and Bazarbachi
A: Arsenic-interferon-alpha-triggered apoptosis in HTLV-I
transformed cells is associated with tax down-regulation and
reversal of NF-kappa B activation. Blood. 96:2849–2855.
2000.PubMed/NCBI
|
|
20
|
Townsend PA, Scarabelli TM, Davidson SM,
Knight RA, Latchman DS and Stephanou A: STAT-1 interacts with p53
to enhance DNA damage-induced apoptosis. J Biol Chem.
279:5811–5820. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lin J, Tang H, Jin X, Jia G and Hsieh JT:
p53 regulates Stat3 phosphorylation and DNA binding activity in
human prostate cancer cells expressing constitutively active Stat3.
Oncogene. 21:3082–3088. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ramana CV, Chatterjee-Kishore M, Nguyen H
and Stark GR: Complex roles of Stat1 in regulating gene expression.
Oncogene. 19:2619–2627. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kinpara S, Kijiyama M, Takamori A,
Hasegawa A, Sasada A, Masuda T, Tanaka Y, Utsunomiya A and Kannagi
M: Interferon-alpha (IFN-alpha) suppresses HTLV-1 gene expression
and cell cycling, while IFN-alpha combined with zidovudine induces
p53 signaling and apoptosis in HTLV-1-infected cells.
Retrovirology. 10:522013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bazarbachi A, El-Sabban ME, Nasr R,
Quignon F, Awaraji C, Kersual J, Dianoux L, Zermati Y, Haidar JH,
Hermine O and de Thé H: Arsenic trioxide and interferon-alpha
synergize to induce cell cycle arrest and apoptosis in human T-cell
lymphotropic virus type I-transformed cells. Blood. 93:278–283.
1999.PubMed/NCBI
|
|
25
|
Nasr R, Rosenwald A, El-Sabban ME, Arnulf
B, Zalloua P, Lepelletier Y, Bex F, Hermine O, Staudt L, de Thé H
and Bazarbachi A: Arsenic/interferon specifically reverses 2
distinct gene networks critical for the survival of HTLV-1-infected
leukemic cells. Blood. 101:4576–4582. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Brown M, Bellon M and Nicot C: Emodin and
DHA potently increase arsenic trioxide interferon-alpha-induced
cell death of HTLV-I-transformed cells by generation of reactive
oxygen species and inhibition of Akt and AP-1. Blood.
109:1653–1659. 2007. View Article : Google Scholar : PubMed/NCBI
|
